文献速递慢性肾脏病水电解质与酸碱

肾结石与膀胱结石患者的终末期肾病及死亡风险

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers.
PubMed 文献 · Am J Kidney Dis · 2018-08-23

该历史性匹配队列研究纳入1984-2012年Olmsted County的6984例结石患者和28044例对照,中位随访12.0年。调整基线合并症后,复发症状性肾结石、无症状肾结石和编码错误结石患者的ESRD风险升高,无症状肾结石和膀胱结石患者全因死亡风险升高。

要点

  • 复发症状性肾结石患者ESRD风险升高(HR 2.34)。
  • 无症状肾结石患者ESRD风险(HR 3.94)和全因死亡风险(HR 1.40)均升高。
  • 膀胱结石患者全因死亡风险升高(HR 1.37),但ESRD风险未显著升高。

核心结论

  • 复发症状性肾结石患者ESRD风险高于初发症状性肾结石患者,提示结石事件与肾损伤相关。
  • 无症状肾结石、编码错误结石和膀胱结石患者的高ESRD或死亡风险可能与影像学指征、诊断错误或膀胱出口梗阻有关。

研究设计与样本

  • 历史性匹配队列研究,纳入1984-2012年Olmsted County的6984例结石患者和28044例年龄性别匹配的非结石对照。
  • 结石患者经病历回顾分为5类:初发症状性肾结石、复发症状性肾结石、无症状肾结石、单纯膀胱结石和编码错误(无结石)。

主要发现

  • 平均随访12.0年,结石患者ESRD发生率为0.93%(65/6984),非结石对照为0.36%(102/28044)。
  • 调整基线高血压、糖尿病、血脂异常、痛风、肥胖和CKD后,复发症状性肾结石(HR 2.34;95% CI 1.08-5.07)、无症状肾结石(HR 3.94;95% CI 1.65-9.43)和编码错误结石(HR 6.18;95% CI 2.25-16.93)的ESRD风险升高。
  • 初发症状性肾结石和膀胱结石患者的ESRD风险未显著升高。
  • 无症状肾结石(HR 1.40;95% CI 1.18-1.67)和膀胱结石(HR 1.37;95% CI 1.12-1.69)患者的全因死亡风险升高。

关键数值与推荐

  • 复发症状性肾结石患者ESRD风险HR 2.34(95% CI 1.08-5.07)。
  • 无症状肾结石患者ESRD风险HR 3.94(95% CI 1.65-9.43),全因死亡风险HR 1.40(95% CI 1.18-1.67)。
  • 编码错误结石患者ESRD风险HR 6.18(95% CI 2.25-16.93)。
  • 膀胱结石患者全因死亡风险HR 1.37(95% CI 1.12-1.69)。

临床怎么用

  • 对复发症状性肾结石患者应关注肾功能监测,因其ESRD风险升高。
  • 无症状肾结石患者需评估影像学检查指征,并警惕ESRD和死亡风险升高。
  • 膀胱结石患者应排查膀胱出口梗阻等原因,因其全因死亡风险升高。
  • 编码错误结石患者的不良结局风险高,提示需核实诊断准确性。

局限性

  • 观察性设计无法确立因果关系。
  • 结石分类依赖病历回顾和ICD-9编码,可能存在错分。
  • 无症状和编码错误结石患者的不良结局可能与尿路感染、癌症或肌肉骨骼/胃肠道疼痛等诊断相关。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVES: Kidney stones have been associated with increased risk for end-stage renal disease (ESRD). However, it is unclear whether there is also an increased risk for mortality and if these risks are uniform across clinically distinct categories of stone formers. STUDY DESIGN: Historical matched-cohort study. SETTING & PARTICIPANTS: Stone formers in Olmsted County, MN, between 1984 and 2012 identified using International Classification of Diseases, Ninth Revision codes. Age- and sex-matched individuals who had no codes for stones were the comparison group. PREDICTOR: Stone formers were placed into 5 mutually exclusive categories after review of medical charts: incident symptomatic kidney, recurrent symptomatic kidney, asymptomatic kidney, bladder only, and miscoded (no stone). OUTCOMES: ESRD, mortality, cardiovascular mortality, and cancer mortality. ANALYTICAL APPROACH: Cox proportional hazards models with adjustment for baseline comorbid conditions. RESULTS: Overall, 65 of 6,984 (0.93%) stone formers and 102 of 28,044 (0.36%) non-stone formers developed ESRD over a mean follow-up of 12.0 years. After adjusting for baseline hypertension, diabetes mellitus, dyslipidemia, gout, obesity, and chronic kidney disease, risk for ESRD was higher in recurrent symptomatic kidney (HR, 2.34; 95% CI, 1.08-5.07), asymptomatic kidney (HR, 3.94; 95% CI, 1.65-9.43), and miscoded (HR, 6.18; 95% CI, 2.25-16.93) stone formers, but not in incident symptomatic kidney or bladder stone formers. The adjusted risk for all-cause mortality was higher in asymptomatic kidney (HR, 1.40; 95% CI, 1.18-1.67) and bladder (HR, 1.37; 95% CI, 1.12-1.69) stone formers. Chart review of asymptomatic and miscoded stone formers suggested increased risk for adverse outcomes related to diagnoses including urinary tract infection, cancer, and musculoskeletal or gastrointestinal pain. CONCLUSIONS: The higher risk for ESRD in recurrent symptomatic compared with incident symptomatic kidney stone formers suggests that stone events are associated with kidney injury. The clinical indication for imaging in asymptomatic stone formers, the correct diagnosis in miscoded stone formers, and the cause of a bladder outlet obstruction in bladder stone formers may explain the higher risk for ESRD or death in these groups.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Dhondup T, Kittanamongkolchai W, Vaughan LE, et al. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. Am J Kidney Dis. 2018. PMID: 30146423. doi:10.1053/j.ajkd.2018.06.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。